0
0
56 words
0
Comments
New research uses AlphaFold, an artificial intelligence (AI)-powered protein structure database, to accelerate the design and synthesis of a drug to treat hepatocellular carcinoma (HCC), the most common type of primary liver cancer. It is the first successful…
You are the first to view
https://phys.org/news/2023-01-alphafold-ai-drug-liver-cancer.html
Create an account or login to join the discussion